SEC Form 4 · accession 0001562180-17-003871
PALVELLA THERAPEUTICS, INC. · PVLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James A Geraghty
Director
Period of report
Dec 12, 2017
Accepted (ET)
Dec 14, 2017 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583648
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $5.79 | Dec 12, 2017 | A | 40,000 | A | — | Dec 12, 2028 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1The option vests as to 25% of the option shares on November 15, 2018 and vests as to an additional 6.25% of the option shares at the end of each full fiscal quarter thereafter.